PharmaShots | Incisive News in 3 Shots

Subscribe Now

Teva

Insights+ Key Biosimilars Events of May 2024

Insights+ Key Biosimilars Events of May 2024

June 4, 2024

Teva and Alvotech Launches Simlandi (Biosimilar, Humira) Injection Across US to Treat Multiple Indications

Teva and Alvotech Launches Simlandi (Biosimilar, Humira) Injection Across US to Treat Multiple Indications

May 20, 2024

Teva and Alvotech’s Selarsdi (Biosimilar, Stelara) Receives the US FDA’s Approval

Teva and Alvotech’s Selarsdi (Biosimilar, Stelara) Receives the US FDA’s Approval

April 17, 2024

Teva Presents P-IV (UNITE) Study Results of Ajovy (fremanezumab) for Migraine and Major Depressive Disorder at World Congress of Neurology

Teva Presents P-IV (UNITE) Study Results of Ajovy (fremanezumab) for Migraine and Major Depressive Disorder at World Congress of N...

October 17, 2023

Insights+: The US FDA New Drug Approvals in May 2023

Insights+: The US FDA New Drug Approvals in May 2023

June 22, 2023

Teva and MedinCell Receive the US FDA’s Approval of Uzedy (risperidone) Extended-Release Injectable Suspension for Schizophrenia

Teva and MedinCell Receive the US FDA’s Approval of Uzedy (risperidone) Extended-Release Injectable Suspension for Schizophrenia

May 1, 2023

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us